Biopsies from synovial joints — and the abundance of B cells and macrophages therein — may instruct more effective treatment decisions for individuals with rheumatoid arthritis.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Smolen, J. S. et al. Nat. Rev. Dis. Primers 4, 18001 (2018).
Fraenkel, L. et al. Arthritis Care Res. 73, 924–939 (2021).
Pitzalis, C., Choy, E. H. S. & Buch, M. H. Nat. Rev. Rheumatol. 16, 590–599 (2020).
Donlin, L. T. et al. Nat. Rev. Rheumatol. 15, 327–399 (2019).
Rivellese, F. et al. Nat. Med. https://doi.org/10.1038/s41591-022-01789-0 (2022).
Humby, F. et al. Lancet 397, 305–317 (2021).
Bykerk, V. & Emry, P. Arthritis Rheum. 62, 3519–3521 (2010).
Burmester, G. R. & Pope, J. E. Lancet 389, 2338–2348 (2017).
Aletaha, D. & Smolen, J. S. JAMA 320, 1360–1372 (2018).
Zhang, F. et al. Preprint at bioRxiv https://doi.org/10.1101/2022.02.25.481990 (2022).
Alivernini, S. et al. Nat. Med. 26, 1295–1306 (2020).
Kuo, D. et al. Sci. Transl. Med. 11, eaau8587 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
L.T.D. is a member of the NIH-industry sponsored Accelerating Medicines Partnership consortium.
Rights and permissions
About this article
Cite this article
Donlin, L.T. Inching closer to precision treatment for rheumatoid arthritis. Nat Med 28, 1129–1131 (2022). https://doi.org/10.1038/s41591-022-01857-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-01857-5